Immuron (IMRN) Total Liabilities (2016 - 2025)
Immuron (IMRN) recorded quarterly Total Liabilities of $20607.9 in Q3 2025, down 98.44% quarter-over-quarter from $1.3 million in Q2 2025, and down 27.45% on a YoY basis from $28405.2 in Q3 2024.
Immuron (IMRN) Total Liabilities (2016 - 2025) Analysis & Trends
Immuron's Total Liabilities history runs 10 years deep, the most recent figure standing at $20607.9 for Q3 2025.
- In Q3 2025, Total Liabilities fell 27.45% year-over-year to $20607.9; the TTM figure through Sep 2025 stood at $20607.9 (down 27.45% YoY), while the FY2025 annual figure was $20607.9, down 27.45% from the prior year.
- Total Liabilities was $20607.9 for Q3 2025 at Immuron, down from $1.3 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.9 million in Q2 2024 to a low of $8781.5 in Q4 2021.
- Historically, Total Liabilities has averaged $856338.2 across 5 years, with a median of $1.1 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Total Liabilities jumped 12457.8% in 2022, then slumped 98.61% in 2023.
- A 5-year view of Total Liabilities shows it stood at $8781.5 in 2021, then surged by 12457.8% to $1.1 million in 2022, then plunged by 98.61% to $15338.6 in 2023, then jumped by 7703.14% to $1.2 million in 2024, then sank by 98.28% to $20607.9 in 2025.
- The last three Total Liabilities figures came in at $20607.9 (Q3 2025), $1.3 million (Q2 2025), and $1.2 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Immuron | 921.61 Mn | 921.58 Mn | - | 20,607.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 20,607.86 |
| Jun 30, 2025 | 1.32 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 9, 2024 | 28,405.25 |
| Jun 30, 2024 | 1.87 Mn |
| Dec 31, 2023 | 15,338.64 |
| Sep 28, 2023 | 1.55 Mn |
| Aug 30, 2023 | 23,713.46 |
| Jun 30, 2023 | 1.58 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Aug 31, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.20 Mn |
| Dec 31, 2021 | 8,781.48 |
| Jun 30, 2021 | 891,761.59 |
| Dec 31, 2020 | 5,230.51 |
| Sep 1, 2020 | 558,250.00 |
| Jun 30, 2020 | 365,888.56 |
| Dec 31, 2019 | 5.58 Bn |
| Jun 30, 2019 | 847,929.39 |
| Dec 31, 2018 | 521,234.00 |